AI healthcare and AI pharmaceutical concepts are experiencing volatile adjustments, with PR falling over 18%, R&G Pharma down nearly 15%, and IMIC, BOJI CRO, GOODWILL, and Berry Genomics all dropping more than 5%Wallstreetcn·Jan 14 at 07:50 PM301230+8.38%301333+3.35%
PR: At this stage, the direct revenue from the company's DiOrion platform drug development services accounts for a small proportion of the company's overall operating income, which does not have a significant impact on the company's overall operating situationWallstreetcn·Jan 14 at 05:57 AM301230+8.38%
PR released its performance for the first three quarters, with a net profit attributable to the parent company of 34.7496 million yuan, an increase of 127.96%Zhitong·Oct 29, 2025 at 04:54 AM301230+8.38%
PR: It plans to distribute 13.754 million yuan in cash for the first three quarters of 2025Zhitong·Oct 29, 2025 at 02:58 AM301230+8.38%
The innovative drug concept surged in the afternoon, with Nossan hitting the 20% limit up, followed by gains in PR, Tigermed, Jiuzhou Pharma, and HighfineZhitong·Oct 29, 2025 at 12:15 AM301230+8.38%300347+1.96%
PR: The company's business includes the weight loss sectorZhitong·Sep 24, 2025 at 08:19 PM301230+8.38%
PR: In the first half of 2025, the net profit was 24.7614 million yuan, a year-on-year increase of 54.99%Zhitong·Aug 27, 2025 at 08:41 AM301230+8.38%
The CRO concept surged sharply at the beginning of the session, with ChemPartner rising over 11%, HUIYU PHARMACEUTICAL, SNSW, CTI, and PR all rising over 5%Zhitong·Jul 7, 2025 at 08:37 PM688117+3.08%300012+0.56%
Shareholder of PR, Shenyang Fubang, has completed a reduction in holdings, with a total reduction of 1% of sharesZhitong·Jun 6, 2025 at 06:48 AM301230+8.38%
The medical services sector has seen a short-term decline, with Kingchem falling over 8%Zhitong·Jun 4, 2025 at 08:33 PM301096+5.17%688222+4.98%
PR: Shenyang Fubon plans to reduce its holdings of no more than 1% of the company's sharesZhitong·May 6, 2025 at 09:42 AM301230+8.38%
CRO concept stocks fluctuate and strengthen, PR rises over 10%36Kr·Apr 28, 2025 at 09:17 PM603259+2.35%02359+1.90%
PR released its first-quarter performance, with a net profit attributable to the parent company of 11.9739 million yuan, an increase of 226.47%Zhitong·Apr 28, 2025 at 09:04 AM301230+8.38%
The smart medical sector opened high, with PR rising over 8%Zhitong·Apr 24, 2025 at 08:28 PM301230+8.38%301103+1.74%
PR released its 2024 annual performance, with a net profit attributable to the parent company of 17.0832 million yuan, a year-on-year decrease of 54.59%Zhitong·Apr 23, 2025 at 09:07 AM301230+8.38%
